Patrick Casara

USPTO Granted Patents = 22 (Patent Applications = 1)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 143(Granted Patents)

Location History:

Truchtersheim, FR (1983 - 1984)
Ittenheim, FR (1995 - 1999)
Vilennes sur Seine, FR (2009)
Villennes sur Seine, FR (2002 - 2011)
Strasbourg, FR (1978 - 2020)

Company Filing History:

9 out of 290

Les Laboratoires Servier

Merrell Pharmaceuticals, Inc.

patents

4. 3 out of 455

Merrell Dow Pharmaceuticals

patents

5. 3 out of 48

Merrell Toraude Et Compagnie

patents

6. 2 out of 53

Les Laboratories Servier

Merrell Toruade Et Compagnie

patent

where one patent can have more than one assignee

Years Active: 1978-2020

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10662173 - Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them (2020-05-26),

2. 10258626 - Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them (2019-04-16),

3. 9765056 - Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them (2017-09-19),

4. 9603854 - Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them (2017-03-28),

5. 9120791 - Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them (2015-09-01),

6. 8008337 - Azabicyclo[3.2.0] hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them (2011-08-30),

7. 7906547 - Azabicylic compounds, a process for their preparation and pharmaceutical compositions containing them (2011-03-15),

8. 7576120 - Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them (2009-08-18),

9. 6846833 - Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same (2005-01-25),

10. 6638962 - Cycloheptene compounds (2003-10-28),

11. 6605604 - Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them (2003-08-12),

12. 6350759 - Dihydro- and tetrahydro-quinoline compounds (2002-02-26),

13. 5922696 - Ethylenic and allenic phosphonate derivatives of purines (1999-07-13),

14. 5817647 - Unsaturated acetylene phosphonate derivatives of purines (1998-10-06),

15. 5512698 - Ethyl 6-formyloxy-4-hexenoate (1996-04-30),

Title: The Innovative Journey of Patrick J Casara

Introduction: Patrick J Casara is a renowned inventor based in Strasbourg, France, known for his groundbreaking contributions to various fields through his inventive spirit and dedication to innovation.

Latest Patents: Patrick J Casara holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced medical devices, showcasing his versatility and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, Patrick J Casara has worked with leading research institutions and multinational companies to bring his innovative ideas to life. His passion for creating solutions that make a positive impact on society has driven him to push the boundaries of traditional thinking.

Collaborations: Throughout his career, Patrick J Casara has collaborated with top engineers, scientists, and designers to develop cutting-edge products that have revolutionized their respective industries. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Patrick J Casara's relentless pursuit of innovation and his commitment to excellence have established him as a prominent figure in the world of inventors. His continued dedication to creating solutions that address global challenges underscores his status as a visionary inventor shaping the future of technology.

This text is generated by artificial intelligence and may not be accurate.